Clozapine is a trlcyclic dibenzodiazepine derivative that is classified as an "atypical" antipsychotic drug. A 25-year-old male was brought to a hospital emergency room following the ingestion of an estimated 20 100-rag tablets of clozapine. After several hours in the hospital, the patient died. The cause of death was listed as acute clozapine intoxication. It was also noted upon autopsy that the patient had an unusual eosinophilic myocarditis. The toxicological and pathological findings are presented in this report.
Introduction
Clozapine is a tricyclic dibenzodiazcpine deriwltive that is classified as an "atypical" antipsychotic drug. Its mechanism of action is primarily via an inte,'action with dopamine receptors in the brain's limbic area ( I ). Clozapine was made available in the United States market in February 1990 under the trade name ClozariF ~ (2) and has been on the Eu,'opean market since the 1970s under the trade name Leponex~L It is available in tablets of 25 and 100 mg for oral administration. Because of the risk of agranulocytosis and seizures associaled with its use, clozapine is recommended only for those cases in which patients have failed to respond adequately to standard antipsychotic drugs (1) .
Relatively few cases of death resulting from an overdose of clozapine have been reported. This report describes clozapine tissue concentrations and pathological findings following an apparent overdose of Clozaril.
Case History
A 25-year-old, 231-1b. male was brought to the emergency room of a local hospital at I 1:45 p.m. by his family, who suspected an overdose of medication. The patient had unsuccessfully attempted suicide with an overdose of haloperidol four years prior. His psychiatrist had recently started him on a prescription of clozapine (Clozaril). It was estimated that the patient took 20 100-mg clozapine tablets at 8:30 p.m. that evening. He appeared agitated, confused, combative, uncooperative, and requil'ed restraints throughout the procedures in the emergency room. At 12:45 a.m., blood was obtained for hospital laboratory work. A gastric lavage was performed at 1:50 a.m. with 6 L of normal saline solution. Large amounts of pill fragments and undigested food were recovered following the lavage. At 2:05 a.m., the patient was observed to turn blue and have a cardiac retest, at which time CPR was initiated until his expiration at 2:31 a.m.
An autopsy was performed on the decedent approximately eight hours after death. The cause of death listed by the pathologist was acute clozapine intoxication. With the exception of cardiomegaly (440 g) and left ventricular hypertrophy, the gross pathologic findings were nonspecific for, but consistent with, acute drug intoxication. The etiology of the cardiac enlargement was not apparent anatomically or by clinical history. The microscopic description of the myocardium is discussed in a later section of this paper.
Methods
Toxicological analyses were perlbrmed on the blood obtained at the hospital emergency room (antemortem blood), postmortem heart blood, urine, liver, and gastric contents. Clozapine was extracted from the tissues utilizing a modification of the procedure described by Foerster et al. (3) . Briefly, the procedure involved using 0.2, 0.5, and 1.0 mL of antemortem and postmortem blood, 1.0 and 2.0 mL or urine at a I: 10 (v/v) dilution; 0. l, 0.2, and 0.5 mL of a 20% (w/w) liver homogenate; and 0.1 and 0.2 mL of the gastric solution.
After the addition of three drops of concentrated NH4OH, 200 laL of prazepam at 10 lag/mL was added to each specimen as an internal standard. After mixing, 2 mL of saturated sodium borate (pH 9.5) and 5 mL of l-chlorobutane were added to each tube. The samples were then mixed and centrifuged, and the l-chlorobutane layer was transferred to separate test tubes and evaporated to dryness. The residue was taken up in 50/.aL of ethyl acetate for gas chromatographic (GC) analysis.
Quantitation of clozapine was performed by dual column gas chromatography using a modification of the procedure of Watts and Simonick (4) . A Hewlett-Packard GC equipped with a nitrogen-phosphorus detector was used for analysis. Separation and quantitation involved dual fused-silica megabore capillary columns (DB-1, t5 m x 0.542 mm i.d. with a 1.5-gM film thickness and DB-17, 15 m x 0.545 mm i.d. with a 1.0-1xM film thickness). The operating parameters consisted of an isothermal column temperature of 250~ with the injector and detector temperatures at 250~ and 300~ respectively.
Gas chromatography/mass spectrometry (GC/MS) analysis was performed on a Hewlett-Packard 5890/5970 GC/MS equipped with a fused-silica capillary column (DB-1, 15 m x 0.25 mm, i.d.). The operating parameters consisted of a column temperature program at 150~ (2 min) to 290~ (5 min) at 15~
The injector and detector temperatures were 250~ and 300~ respectively. The data acquisition was in the scan mode with a mass range of 40 to 500 amu.
Results
The structures of the tncyclic dibenzodiazepine clozapine and its N-demethylated metabolite, norclozapine, are presented in Figure 1 . GC/MS analysis determined that the five most abundant ions and relative percentages for clozapine were 243 (100%), 256 (89%), 70 (56%), 192 (49%), and 42 (47%) with a molecular ion of 326 (12%). Norclozapine produced ions of 243 (100%), 244 (67%), 256 (44%), 192 (39%), and 245 (33%) with a molecular ion of 3t2 (31%).
Upon GC/NP analysis, the retention times for clozapine and norclozapine on the DB-1 column were 5.098 and 5.231 min with the internal standard, prazepam, eluting at 4.275 min. The retention times for clozapine and norclozapine on the DB-17 column were 6.410 and 7.007 rain with prazepam eluting at 5.418 min.
The tissue concentrations for clozapine are presented in Table I . Antemortem and postmortem clozapine blood concentrations were 1.94 and 5.81 gg/mL, respectively, while the urine had 11.3 laglmL. The liver had 42.9 ggfg of clozapine and the gastric contained a total of 6.5 mg. Norclozapine was detected in some tissues but not quantitated because we lacked a proper standard. The percentages of norclozapine relative to clozapine were determined based on the area of the responses for the drugs upon GC/NP analysis (Table I) . Antemortem and postmortem blood contained norclozapine at 10.8% and 12.0%, respectively, while the urine had only 7.8% of norclozapine relative to clozapine. The liver norclozapine percentage was 52.6% while the gastric contents had no detectable amount of norclozapine. 
Discussion
Clozapine undergoes N-demethylation to form the metabolite norclozapine. The identification of norclozapine in this case was primarily via the mass spectral data (Figure 2 ). Clozapine has a molecular ion of 326 amu while the spectrum for norclozapine had a molecular ion 14 mass units less, at 312 amu, indicating the loss of a methyl group. Both compounds had similar spectra including the typical chloride atom pattern seen with many benzodiazepine drugs. Table II summarizes the sequence of events leading to the expiration of the decedent. As can be seen, approximately 20 100-mg tablets of Clozaril were ingested at 8:30 p.m. The clozapine concentration of the blood sample taken approximately 4 h later, at 12:45 a.m., was 1.94 gg/mL. The patient was given a gastric lavage 5 hours and 20 min after the ingestion and eventually died 6 h after taking the overdose of clozapine. The postmortem clozapine heart blood concentration was 5.81 gg/mL.
Following oral dosages of t00 mg twice daily, the average steady state peak plasma concentration of clozapine was 0.32 gg/mL (range: 0.10--0.77 gg/mL), occurring at an average of 2.5 h (range: I-6 h) after dosing (l). One case of suicide has been reported in which the patient took 3 g of clozapine while 11 other individuals have survived ingestion of more than 4 g (5). Schuster et al. (1977) reported a case in which a patient that was admitted 4 h after the ingestion of 3 g of clozapine subsequently recovered and was released three days later. Vesterby et al. reported two deaths attributed, in part, to clozapine intoxication and reported a clozapine blood concentration of 4.5 gg/mL and a plasma clozapine concentration of 3.2 gg/mL. In the case in- volving the 4.5-1ag/mL concentration, the death was attributed to an accidental overdose caused by drug accumulation, primarily because of a low concentration in the gastric contents (0.4 mg total clozapine). It was also noted by the authors that the decedent had severe acute myocarditis with diffuse infiltration by mononuclcar cells, predominantly histiocytes, and some granulocytes, The microscopic examination of the heart in the present case revealed d~e presence of a striking myocarditis. The process, in contrast to lbe case reported by Vesterby et al., was of an intense interstitial infiltrate of eosinophiles associated with nmcrophages and occasional polymorphonuclear let, kocytes and plasma cells. The inflammation was often perivascuhtr, but there yeas no evidence of wtsculilis. Muscle necrosis was not a predominant finding, but it was deEnitely multi focally present. These findings ,'aised the question of the decedent's possible use of L-tryplophan, but no such history could be obtained from the decedent's physician or mother.
A few repo,'ts from outside the United States have described myocarditis in patients ,'eceiving clozapine (8). The type of my_ ocarditis is not clear in most cases and its relationship, if any, to clozapme remains unclear. In some cases, the diagnosis was made by electrocardiography only. None of the case reports revealed the presence of eosinophilic myocarditis although, interestingly, several patients did develop some degree of peripheral eosinophilia during the course of myocarditis.
Norclozapine was identified in all specimens analyzed except the gastric contents in the present case. The percentages of norclozapine, relative to clozapine, were similar in antemortem blood, postmortem blood, and urine (10.8, 12.0, and 7.8%, ,'espectively). The liver had a substantially higher norclozapmc percentage (52.6%). Clozapine is reported to be completely metabolized before excretion with only trace amounts of unchanged d,'ug detected in the urine (1) . The present case shows a considerable amount of clozapine in the urine ( 11.3 gg/mL) with an appzu'ent lesser amount of norclozapine. Although this could simply be pmlly the result of differences in analytical detection, it is possible that the clozapine/norclozapine urine ratio could be used as a sign in cases of suspected acute clozapine overdose.
The antemortem blood concentration of 1.94 lag/mL may well be a good indicator ot' a lethal concentration of clozapine. This concentration occmTed approximately 4 h after the suspected overdose, which is within the time required for peak clozapine concentrations to be achieved. The postmortem blood concentration (5,81 lag/mL) was approximately three times the antemortem blood concentration. A gastric lavage was given approximately 1 h aRer the antemortem blood specimen was obtained. This would tend to mininaize further absorption of clozapine from the stomach. Thus, with the time allowed for clozapine absorption before the first blood specimen was drawn (4 h) and the subsequent gastric lavage, the increase seen with the postmortem clozapine heart blood concentration may be the result of postmortem redistribution, As previously mentioned, I I individuals have survived following the ingestion of more than 4 g of Clozaril. The present case involves a relatively large man (231 lb.) who died after the ingestion of only 2 g of Clozaril and who also had severe my, ocarditis. Thus, although the quantity of clozapine ingested may be fatal in itself, it is also possible that the myocarditis could have compromised the decedents chance for survival.
